跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NIVEA MEN SENSITIVE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NIVEA MEN SENSITIVE
Authorized
STANDARD
NIVEA MEN SENSITIVE
beiersdorf canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a1bc831d1ba6e7d5
Company
beiersdorf canada inc
Type
Standard
Approval Details
Approval Id
a1bc831d1ba6e7d5
Drug Approval Canada Name
NIVEA MEN SENSITIVE
Product Name
NIVEA MEN SENSITIVE
Status
Marketed
Status Date
2021-03-10
Original Market Date
2021-03-10
Din
02507692
Drug Class
Human
Dosage Form
Cream
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:80.00
Atc Original
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name
d 02 ba 30
Aig Number
0335121032
Company Name
beiersdorf canada inc
Company Address
2344 Alfred-Nobel Blvd.,Suite 100a, St-Laurent, Quebec, Canada, H4S 0A4
Active Ingredients
OCTISALATE
4.7 % / W/W
OCTOCRYLENE
8.4 % / W/W
AVOBENZONE
3 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a1bc831d1ba6e7d5
Type
Standard
Back to Health Canada Approvals